YY1 inhibits SHLD1 transcription, thereby leading cross-resistance to poly ADP-ribose polymerase (PARP) inhibitor and cisplatin in breast cancer susceptibility gene 1 (BRCA1)-deficient ovarian cancer cells [85]. The gene discussed is YY1; the disease is ovarian carcinoma.